Why Is Cimpress (CMPR) Up 12.9% Since Last Earnings Report?

Cimpress (CMPR) shares have gained 12.9% since its Q4 fiscal 2025 earnings report, outperforming the S&P 500, despite the company reporting an adjusted loss of $1.02 per share, significantly missing consensus estimates, while revenues of $869.5 million surpassed expectations with 4.4% year-over-year growth. For fiscal 2026, Cimpress forecasts 5-6% revenue growth and adjusted EBITDA of at least $450 million, alongside a commitment to reduce net leverage. However, analyst earnings estimates have seen a substantial 55.56% downward revision in the past month, contributing to a Zacks Rank #3 (Hold) and an expectation for in-line stock performance.

Analysis

Cimpress (CMPR) presents a contradictory picture for investors, as its shares rallied 12.9% post-earnings, significantly outperforming the S&P 500, despite a substantial miss on profitability. The company reported a fourth-quarter adjusted loss of $1.02 per share, a stark reversal from the $4.33 earnings per share in the prior-year quarter and well below the consensus estimate of a $0.97 profit. This earnings shortfall was driven by margin pressure, with gross margin contracting by 110 basis points to 47.5% as the cost of revenues outpaced sales growth. Offsetting this, total revenues grew 4.4% to $869.5 million, beating estimates, with all business segments contributing to the top-line growth. The market's positive reaction appears to be anchored in the company's fiscal 2026 guidance, which projects 5-6% revenue growth, at least $450 million in adjusted EBITDA, and a commitment to reduce net leverage. However, this optimism is not shared by analysts, whose consensus estimates have been revised downward by a notable 55.56%, signaling deep concerns over the company's profitability and leading to a Zacks Rank #3 (Hold).

Key Decisions for Investors

• Investors should be cautious of the recent 12.9% share price rally, as it contrasts sharply with the significant Q4 earnings miss, eroding margins, and a 55.56% downward revision in analyst consensus estimates.
• Future performance hinges on management's ability to deliver on its fiscal 2026 guidance, making the achievement of its projected $450 million in adjusted EBITDA and a tangible reduction in net leverage critical metrics to monitor.
• Given the conflicting signals of strong value and growth scores against a poor momentum score and a 'Hold' rating, a neutral stance may be prudent until there is clear evidence of a sustained recovery in profitability and margin expansion.